BioCryst Pharmaceuticals BCRX Total costs & expenses

Total costs & expenses at other companies

Ionis PharmaceuticalsIONS

$370.24M+18.6%

BridgeBio PharmaBBIO

$300.47M+36.0%

Agios PharmaceuticalsAGIO

$155.3M+11.3%

Acadia PharmaceuticalsACAD

$270.12M+16.3%

Aquestive Therapeutics, Inc.AQST

$18.65M-33.6%

RegenxbioRGNX

$78.76M-6.9%

FAQ

What is BioCryst Pharmaceuticals's total costs & expenses?

BioCryst Pharmaceuticals (BCRX) reported total costs & expenses of $119.79M in Q2 2026.

How has BioCryst Pharmaceuticals's total costs & expenses changed year-over-year?

BioCryst Pharmaceuticals's total costs & expenses decreased by 10.3% year-over-year, from $133.57M to $119.79M.

What is the long-term trend for BioCryst Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's total costs & expenses has grown at a 12.4% compound annual growth rate (CAGR), from $334.89M to $533.85M.

What does total costs & expenses mean?

The aggregate of all operating and non-operating costs incurred by the company during a reporting period, including research and development, selling, general, and administrative expenses. This metric provides a comprehensive view of the total resource consumption required to sustain business operations and drug development pipelines.